Building the future

Bruno Gridelli

IRCCS - ISMETT

The Ri.MED Foundation was established as an international partnership betweenthe Italian Government, the Presidency of the Region of Sicily, the Italian NationalResearch Council (CNR), the University of Pittsburgh and the University ofPittsburgh Medical Center (UPMC).

The Ri.MED Foundation

BIRTH AND GOALS

to promote, support, and conduct biotech and biomedical research projects to rapidly transfer innovative results in the clinical practice:

Spreading scientific culture

Training scientific, technical and administrative staff with specific skills in biotechnology

Creating and directly and/or jointly managing biotechnology research laboratories (BRBC)

Ri.MED

2006

goals

The Foundation is currently focused on the creation of the BiomedicalResearch and Biotechnology Centre (BRBC) in Carini, a few miles fromPalermo International Airport.

Biomedical Research and Biotechnology Centre

The BRBC will host 25,000 sqm of laboratory facilities including:

Structural Biology Laboratory

Biomedical Engineering Research Laboratories

Vivarium and Transgenic Rodent Facility

Vaccine Development Laboratories

Molecular Imaging Laboratory

Neuroscience Laboratory

Core Laboratories

Spin-off Incubator

BRBC

Biomedical Research and Biotechnology Centre

REALIZATION STEPS

The design of the Esecutivo project, delivered in May 2015, is about to be

validated:

Next stage: work assignment, preparing and performing the tender and

drafting the contract.

Works will start by 2016, and end by 2019

BRBC

A public-private management model, able to:

dialogue with universities and research institutes as well as pharmaceutical and biotechnology companies

develop strategic alliances and attract funding and investment for scientific research

Biomedical Research and Biotechnology Centre

a World-class Biotech Industry in Southern ItalyBRBC

new product development

scientific discoveries

commercial products

economic benefit

employment and allied activities

clinical products

social benefit

public health

Ri.MED human resources

Our Research

ers

HR

our Researchers

Ri.MED human resources HR

EMPLOYMENT OF HUMAN RESOURCES

Average age:36,2 years

Gender:45 % man

55 % woman

Ri.MED human resources HR

74%

20%

6%

STAFF’S ORIGIN

Sicily

rest of Italy

foreign countries

23%

50%

27%

DISTRIBUTION

Grants funded researchers

Ri.MED Fellows

Administrative

The Foundation has collaborative research agreements with some

of the leading the biomedical research and biotechnologyinstitutions.

NETWORKINGScientificculture

The Ri.MED Foundation has particularly focused on aspects related to scientificdissemination and sharing of research outcomes. Several meetings,

conferences, keynote lectures, and international workshops have been

organized and have attracted a vast international audience of researchers

SPREADING SCIENTIFIC CULTURE

Each year Ri.MED organizes a major scientific Symposium

Periodically Ri.MED organizes international workshops withEuropean partners like IPR Helpdesk, EATRIS, CNR, Fit forHealth 2.0 and more

Scientificculture

Ri.MED is constantly searching and selecting appropriate international, EU,ministerial and regional funding proposals in order to present competitive projectsand launch co-financed research programs.

During the last 4 years, Ri.MED obtained European funding for over 6 million

Euros.

GRANTS APPLICATION

ISPeMI project: Multicenter and

interdisciplinary Institute for PreclinicalExperimentation and Molecular Imaging.

GRANTS

The Foundation has selected valid resources to conduct preclinical research,translational research, and cell therapy production (GMP Facility) programs atRi.MED's Regenerative Medicine and Biomedical Technologies Unit located inthe premises of IRCCS-ISMETT in Palermo.

Alongside a number of projects strongly oriented towards clinical application,inside the Palermo laboratories innovative therapies based on cellular products,such as pancreatic islet transplantation, fetal hepatocyte transplantation andadoptive immunotherapy, are the subject of clinical translation.

Ri.MED Regenerative Medicine and

Biomedical Technologies Unitresearch

Ri.MED Timeline timeline

Thank you